Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice

Fertility and Sterility

Volumn 80, Issue SUPPL. 2, 2003, Pages 788-794

  Zhou, Ying Fang ^b,c   Mori, Takao ^c   Kudo, Hideki ^a   Asakai, Rei ^a   Sassa, Shuji ^a   Sakamoto, Shinobu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b PEKING UNIVERSITY   (China)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis inhibitor; DNA synthesis; Uterine adenomyosis

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE; THYMIDINE KINASE; THYMIDYLATE SYNTHASE; VON WILLEBRAND FACTOR;

ADENOMYOSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HYPOPHYSIS; HYPOPHYSIS GRAFT; IMMUNOHISTOCHEMISTRY; IMPLANTATION; IN VIVO STUDY; MEDICAL RESEARCH; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; REDUCTION; UTERINE BLOOD VESSEL; VASCULAR ENDOTHELIUM;

EID: 0141628347     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00988-9     Document Type: Article

References (31)

1. Mori T., Nagasawa H. Mechanisms of development of prolactin-induced adenomyosis in mice. Acta Anatom. 116:1983;46-54.
2. Mori T, Nagasawa H, Ohta Y. Prolactin and uterine adenomyosis in mice. In: Nagasawa H, ed. Prolactin and lesions in breast, uterine and prostate. Florida: CRC Press, 1989:123-39.
3. Zhou Y.-F., Matsuda M., Sakamoto S., Mori T. Changes in uterine microvessels as a possible pathogenic factor in the development of adenomyosis induced by pituitary grafting in mice. Acta Histochem Cytochem. 32:1999;387-391.
4. Folkman J. Tumor angiogenesis therapeutic implications . N Engl J Med. 285:1971;1182-1186.
5. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (Lond.). 348:1990;555-557.
6. Oliver S.J., Cheng T.P., Banquerigo M.L., Brahn E. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM- 1470, in combination with cyclosporin reduction of vascular endothelial growth factor (VEGF) . Cell Immunol. 166:1995;196-206.
7. O'Reilly M.S., Brem H., Folkman J. Treatment of murine hemangio-endotheliomas with the angiogenesis inhibitor AGM-1470. J Pediatr Surg. 30:1995;325-329.
8. Liekens S., Verbeken E., Vandeputte M., De Clercq E., Neyts J. A novel animal model for hemangiomas inhibition of hemangioma development by the angiogenesis inhibitor TNP-470 . Cancer Res. 59:1999;2376-2383.
9. Herzfeld A., Raper S.M. Relative activities of thymidylate synthetase and thymidine kinase in rat tissues. Cancer Res. 40:1980;744-750.
10. Nawata H., Kamiya T. Two molecular forms of thymidine kinase in the cytosol of regenerating rat liver. J Biochem. 78:1975;1215-1224.
11. Weber G., Kizaki H., Tzeng D., Shiotani T., Olah E. Colon tumor enzymology of the neoplastic program . Life Sci. 23:1978;729-736.
12. Herzfeld A., Legg M.A., Greengard O. Human colon tumors enzymic and histological characteristics . Cancer. 42:1978;1280-1283.
13. Shi Z.-O., Itzkowitz S.H., Kim T.S. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem. 36:1988;317-322.
14. Okayasu I., Ohkusa T., Kajiura K., Kanno J., Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut. 39:1996;87-92.
15. Dunlap R.B., Harding N.G.L., Huennekens F.M. Thymidylate synthetase from amethopterin-resistant Lactobacillus casei. Biochemistry. 10:1971;88-97.
16. Taylor A.T., Stafford M.A., Jones O.W. Properties of thymidine kinase partially purified from human fetal and adult tissue. J Biol Chem. 247:1972;1930-1935.
17. Kase N.G., Weingold A.B., Gershenson D.M. Principle and practice of clinical gynecology. 2nd ed:1990;545-581 Churchill Livingstone, New York.
18. Ota H., Igarashi S., Tanaka T. Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis. Hum Reprod. 13:1998;715-719.
19. Mori T., Nagasawa H., Takahashi S. The induction of adenomyosis in mice by intrauterine pituitary isografts. Life Sci. 29:1981;1277-1282.
20. Ostrander P.L., Mills K.T., Bern H.A. Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure. J Natl Cancer Inst. 74:1985;121-135.
21. Huseby R.A., Tiares M.J., Talamantes F. Ectopic pituitary grafts in mice hormone levels, effects on fertility and the development of adenomyosis uteri, prolactinomas and mammary carcinomas . Endocrinology. 116:1985;1440-1448.
22. Zhou Y.-F., Matsuda M., Mori T., Sakamoto S., Mitamura T. Effects of mifepristone (RU486) treatment on the development of uterine adenomyosis induced by pituitary grafting in mice. Life Sci. 67:2000;2713-2720.
23. Yamashita M., Mori T. Disturbed cell arrangement, increased cell membrane permeability and apoptotic cell death occur in adenomyotic uterine tissues in mice. Zool Sci. 14:1997;659-664.
24. Kusaka M., Sudo K., Matsutani E., Kozai S., Marui S., Fujita T., et al. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Brit J Cancer. 69:1994;212-216.
25. Yamamoto T., Sudo K., Fujita T. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res. 14:1994;1-4.
26. Kanai T., Konno H., Tanaka T., Matsumoto K., Baba M., Nakamura S., et al. Effects of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice. Int J Cancer. 71:1997;838-841.
27. Drevs J., Hofmann I., Hugenschmidt H., Wittig C., Madjar H., Muller M., et al. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res. 60:2000;4819-4824.
28. Schoof D.D., Obando J.A., Cusack J.C. Jr, Goedegebuure P.S., Brem H., Eberlein T.J. The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro. Int J Cancer. 55:1993;630-635.
29. Klauber N., Rohan R.M., Flynn E., D'Amato R.J. Critical components of the female reproductive pathway are suppressed by the angigenesis inhibitor AGM-1470. Nat Med. 3:1997;443-446.
30. Fraser H.M., Dickson S.E., Morris K.D., Erickson G.F., Lunn S.F. The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate. Hum Reprod. 14:1999;2054-2060.
31. Tsujimoto H., Hagiwara A., Osaki K., Ohyama T., Sakakibara T., Sakuyama A., et al. Therapeutic effects of the angiogenesis inhibitor TNP-470 against carcinomatous peritonitis in mice. Anti-Cancer Drugs. 6:1995;438-442.